Wholesale of pharmaceutical and medical goods
GILEAD SCIENCES NORWAY AS
Revenue 2024
NOK 186.2m
Operating profit
NOK 6.5m
Equity
NOK 85.6m
Incorporated
2007
Employees
5
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 186.2m | |
| Total operating costs | 179.7m | |
| Operating profit (EBIT) | 6.5m | |
| Net financial items | 1.0m | |
| Profit for the year | 5.8m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 127.4m | |
| of which current assets | 124.7m | |
| Equity | 85.6m | |
| Total liabilities | 41.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.